Rorze Corporation · TSE:6323
Rorze — Q2 FY2023 Earnings Presentation
27 slides from Rorze's earnings presentation, Oct 12, 2023
Slide 1: FY2023 Second Quarter Financial Briefing
FY2023 Second Quarter (Ended August 31, 2023) Financial Briefing October 12, 2023 RORZE CORPORATION （Code : 6323) https://www.rorze.com/ir 5/8/2019
Slide 2: Disclaimer
Disclaimer ◆ Regarding forward-looking statements The business forecasts and other forward-looking statements contained in this document are based on judgments made in accordance with information currently available for our company and do not constitute a guarantee or promise of the accuracy or comp
Slide 3: Corporate profile
Corporate profile N a m e RORZE CORPORATION Global network 1588-2 Michinoue Kannabe-cho, Fukuyama-shi, Head Office Hiroshima China （Shanghai） Establishment March 30, 1985 Germany Korea (Dresden) （Yongin） Capital 982 million JPY Vietnam Japan （Haiphong・ （Fukuyama・ Bac Ninh） Yokohama・Kumamoto Tsukuba・
Slide 4: FY2023 Second Quarter Consolidated Business Result
FY2023 Second Quarter (March 1～August 31, 2023） Consolidated Business Result 4
Slide 5: Summary of Q2 FY2023
Summary of Q2 FY2023 Profit attributable to Net sales Operating profit Ordinary profit owners of parent 40,992 million JPY 9,952 million JPY 13,878 million JPY 9,835 million JPY YoY YoY YoY YoY ▲10.4% ▲9.0% ▲17.9% ▲20.5% ■ Q2 business results recovers compared to Q1 FY2023 Increase in sales from pre
Slide 6: Q2 FY2023 Consolidated business results
Q2 FY2023 Consolidated business results Forecast Achievement Forecast Achievement （Million JPY） FY’23 Q2 FY’22 Q2 YoY（%) H1 H1(%) Full-year Full-year (%) Net sales 40,992 45,753 89.6 43,127 95.1 88,026 46.6 Semi 34,477 38,964 88.5 35,709 96.6 71,986 47.9 Analysis device 1,521 ― ― 2,087 72.9 3,544 42
Slide 7: Trend in net sales
Trend in net sales （Million JPY） ・Sales in China and USA drives increase to Semi 20.5 billion JPY on a quarterly basis ・The delay in Taiwanese foundries’ factory construction has an impact on Semi sales ・Delivers our flagship product Expert to domestic and international semiconductor Analysis device
Slide 8: Net sales by regions
Net sales by regions （Million JPY） Singapore Others USA China Taiwan Vietnam Europe 2,727 Korea 7% USA 3,981 10% 12,024 Q2 Q3 Q4 Q1 Q2 Q2 Q3 Q4 Q1 Q2 Q2 Q3 Q4 Q1 Q2 29% FY'22 FY'23 FY'22 FY'23 FY'22 FY'23 Japan 4,805 12% Japan Korea Europe Taiwan China 6,598 9,520 16% 23% （Million JPY） ・Unchanged ra
Slide 9: Income statements
Income statements （Million JPY，％） Operating profit 37.5 ・Increase in cost of sales through the JPY 20,000 40 35 depreciation leads to pushing down operating profit 18,000 30 and decline in operating profit ratio 16,000 28.3 26.6 14,000 24.5 21.5 Ordinary profit 25 12,000 9,714 9,750 10,000 8,679 8,6
Slide 10: Trend in orders, net sales, and order backlog (Semi)
Trend in orders, net sales, and order backlog（Semi） Semi ・Orders and net sales increase Backlog decreases modestly but remains at a high level ・In orders from China, major SPEs’ and new customers’ lead increase Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 （Million JPY） FY'20 FY'20 FY'21 FY'21 FY'21 FY'21 FY'
Slide 11: Trend in orders, net sales, and backlog (Analysis device)
Trend in orders, net sales, and backlog（Analysis device） Analysis device ・IAS, joining RORZE in March 2023, receives orders of 500 million JPY for its flagship product, Expert ：Fully Automated VPD, in Q2 FY 2023 Q4 Q1 Q2 （Million JPY） FY'22 FY'23 FY'23 Orders 0 820 497 Net sales 0 715 805 Backlog 4,
Slide 12: Trend in orders, net sales, and backlog (FPD)
Trend in orders, net sales, and backlog（FPD） FPD ・Orders significantly increase to 5 billion JPY, including a bulk order worth approximately 2.6 billion JPY from major customers ・Order details : Mainly INDEX large substrate transfer system, Laser cutting equipment and Display module equipment Q3 Q4
Slide 13: Q2 FY2023 Balance sheet
Q2 FY2023 Balance sheet Assets Liabilities・Net Assets （Million JPY） 148,807 148,807 （Million JPY） 140,392 140,392 Cash & deposits 5,864 Note and accounts 7,734 16,058 126,693 126,482 33,551 126,693 126,482 payable-trade 33,255 Notes & accounts 8,113 7,350 16,435 111,078 111,078 12,401 Short-term bor
Slide 14: Q2 FY2023 Cash-Flow
Q2 FY2023 Cash-Flow （Million JPY） Cash at end of Operating CF Investing CF Financing CF Effect of exchange on cash Cash at end of FY2022 and cash equivalents Q2 FY2023 14
Slide 15: FY2023 Business Forecast
FY2023 Business Forecast 15
Slide 16: Future outlook and forecast for FY2023
Future outlook and forecast for FY2023 ・Capital investment in the semiconductor industry Q2 FY’23 FY’23 gradually recovers from an adjustment phase （Million JPY） FY’23 H1 plan Full-year plan Net sales 40,992 43,127 ・Expects sales increase in the second half, particularly to 88,026 SPEs in China and
Slide 17: Topics
Topics 17
Slide 18: Vietnamese subsidiary receives commendation from the Minister of Planning and Investment
Vietnamese subsidiary receives commendation from the Minister of Planning and Investment of Vietnam ・Vietnamese subsidiary RORZE ROBOTECH CO., LTD. is honored by the Minister of Planning and Investment of Vietnam for its significant contribution to the development and the economic activities of Hai
Slide 19: RORZE SYSTEMS VINA CO., LTD. constructs a new factory
RORZE SYSTEMS VINA CO., LTD. constructs a new factory <Rendering> <Overview of the new factory> Address Bac Ninh Province, Vietnam Schedule Completion : November 2023(Plan) Area Land: 15,000㎡ / Building: Approx. 2,700㎡ 6.4 million USD Investment Land： 2.85 million USD amount Factory： 3.55 million US
Slide 20: Analysis device: New laser ablation device (Expert_LA)
Analysis device : New laser ablation device（Expert_LA) Conventional VPD New product Etching the surface with a chemical solution, Collecting the sample vaporized by laser Sampling method and collecting residues with pure water ablation as it is Accurate quantitative analysis 〇 ◎ Whole-wafer analysis
Slide 21: RORZE Lifescience Inc. exhibits at Regenerative Medicine Japan
RORZE Lifescience Inc. exhibits at ‘Regenerative Medicine Japan’ Exhibiting an automated system for cell culture passaging RORZE Lifescience Inc. is exhibiting at the expo ‘Regenerative Medicine Japan 2023’ Period： October 11 (Wed.) to 13 (Fri.), 2023 Venue： PACIFICO YOKOHAMA 21
Slide 22: Reference
Reference 22
Slide 23: Semi
Semi Unit Equipment Atmospheric Aligner Load Port manufacturers(SPE) Robot Process equipment System Inspection equipment EFEM Vacuum Platform System End -user Device manufacturers Wafer manufacturers Wafer Sorter N2 Purge Wafer Stocker 23
Slide 24: Analysis device
Analysis device Chemical Gas solution Wafer Semiconductor industry SPEｓ End-user GED-Q ASAS Device manufacturers Wafer manufacturers GED MSAG Expert CSI GED_SEMI Other industry Research institution GPD Environmental measuring ASDM Expert_IC instrument manufacturer Laser Ablation Chemical manufacture
Slide 25: FPD
FPD Front-end： FPD manufacturers Glass for FPD manufacturers INDEX extra-large substrate In-line returnable transfer transfer system system Laser cutting equipment RORZE SYSTEMS （Subsidiary in Korea） Back-end： FPD manufacturers Display module equipment Cell type extra-large packing equipment 25
Slide 26: Life science
Life science Drug discovery, Regenerative Incubator CO₂ Incubator with medium exchange medicine SCALE48 function＆cell imaging function CellKeeper®Ⅱ48Plus Mobile robot (universities, pharmaceutical companies) Scheduling software Automatic medium TM Green Button Go ※ exchange system （※Product of Biose
Slide 27: Thank you
Thank you 27